Composition and Myelopeptides
The active principle of these medications is a complex consisting of six myelopeptides. Each has a unique biological role:
- Myelopeptide-1: enhances the functional activity of T-helper cells.
- Myelopeptide-3: specifically stimulates the phagocytic arm of the immune system.
Together, these components trigger proliferation and enhance the functional capabilities of both T- and B-cells.
Pharmacodynamics
The pharmacological effects of Myelopid aim to correct the body's defense mechanisms:
- Restoration of baseline T- and B-system parameters in various immunodeficient states.
- Stimulation of antibody production, actively strengthening the humoral arm.
- General enhancement of the functional activity of immunocompetent cells.
This complex action effectively supports the organism under high immunological stress.
Indications for Use
Clinical use of bone marrow agents is indicated in several key scenarios:
- Combination treatment of secondary immunodeficiencies, particularly those accompanied by marked impairment of the humoral arm.
- Prevention of infectious complications following trauma, surgical interventions, and in the setting of osteomyelitis.
- Therapeutic management of chronic pyodermas and non-specific pulmonary diseases.
Side Effects
Like any biological pharmacological agents, this group of drugs may cause adverse reactions:
- Systemic manifestations: patients may experience generalized weakness, mild dizziness, and nausea.
- Local reactions: pain and local tissue hyperemia are possible at the injection site.